Application of acridinedione compound in preparation of anti-diabetic drug

An acridione, anti-diabetic technology, applied in the field of biomedicine, can solve the problems of increasing hypoglycemia in patients, achieve the effects of promoting insulin secretion, improving insulin resistance, and increasing glucose consumption

Active Publication Date: 2020-06-19
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The hypoglycemic effect of traditional anti-type 2 diabetes drugs is mainly by stimulating the secretion of insulin from pancreatic β cells and improving insulin sensitivity. These effects are not related to peripheral blood sugar. Therefore, the use of these drugs to lower blood sugar will increase the risk of hypoglycemia in patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of acridinedione compound in preparation of anti-diabetic drug
  • Application of acridinedione compound in preparation of anti-diabetic drug
  • Application of acridinedione compound in preparation of anti-diabetic drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0044] The invention will be further described in detail below in conjunction with specific embodiments, which are explanations of the invention rather than limitations.

[0045] An application of an acridione compound or a pharmaceutically acceptable salt or a pharmaceutically acceptable ester thereof in the preparation of an antidiabetic drug, wherein the structure of the acridione compound is as follows.

[0046]

[0047] each R 1 and R 2 independently for hydrogen, C 1-3 Alkyl, COOH, CH 2 Ph, CH 2 CH(CH 3 ) 2 , Ph, or (X = O, N, S);

[0048] each R 3 independently for hydrogen, halogen, CF 3 、C 1-4 Alkyl or alkoxy, NO 2 or OH;

[0049] each R 4 independently for hydrogen, halogen, CF 3 、C 1-4 Alkyl or alkoxy, NO 2 or OH;

[0050] R 5 is carboxyl, potassium carboxylate, sodium carboxylate or calcium carboxylate, methyl carboxylate or ethyl carboxylate;

[0051] n is 0, 1 or 2

[0052] Preferably, the antidiabetic drug is a GPR40 agonist.

[0053] Pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
clearance rateaaaaaaaaaa
Login to view more

Abstract

The invention provides an application of an acridinedione compound in preparation of an anti-diabetic medicine, and belongs to the technical field of biological medicines. According to the invention,the results prove that the acridinedione compound can participate in a GPR40-PPAR gamma-PI3K / Akt-GLUT4 signal path by activating and up-regulating GPR40 protein expression so as to promote insulin secretion, increase glucose consumption of liver and muscle tissues and improve insulin resistance; the action target of the acridinedione compound is a GPR40 receptor, the insulin secretion promoting effect of the acridinedione compound has glucose dependence, and when the peripheral blood glucose is lower than a certain degree, the blood glucose reducing effect of the acridinedione compound disappears; and the acridinedione compound is prepared into the anti-diabetic medicine, and brand-new selection and strategy are provided for treatment of diabetes mellitus.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and particularly relates to the application of acridinediones in the preparation of antidiabetic drugs. Background technique [0002] At present, about 463 million adults aged 20 to 79 worldwide suffer from diabetes, among which type 2 diabetes (T2DM) accounts for more than 90% of the total number of diabetic patients. According to statistics, in 2019, the number of deaths caused by diabetes and its complications was as high as 4.2 million. Diabetic patients in China have reached 116 million, accounting for about a quarter of the total number of diabetic patients in the world. In 2019, the number of deaths caused by diabetes and its complications in my country was about 823,000. Type 2 diabetes has become an important problem affecting human health. The hypoglycemic effect of traditional anti-type 2 diabetes drugs is mainly through stimulating the secretion of insulin by pancreatic β cells ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D219/06C07D405/14C07D409/14A61P3/10
CPCC07D219/06C07D405/14C07D409/14A61P3/10A61K31/473
Inventor 刘雪英沈歆刘吉元张生勇王庆伟张杰魏朝张东旭梁佳龙张鑫磊
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap